Yanhong Gu

4.4k total citations
118 papers, 3.2k citations indexed

About

Yanhong Gu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yanhong Gu has authored 118 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Oncology, 40 papers in Molecular Biology and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yanhong Gu's work include Colorectal Cancer Treatments and Studies (20 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Immune Cell Function and Interaction (13 papers). Yanhong Gu is often cited by papers focused on Colorectal Cancer Treatments and Studies (20 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Immune Cell Function and Interaction (13 papers). Yanhong Gu collaborates with scholars based in China, United States and Czechia. Yanhong Gu's co-authors include Qiang Xu, Yang Sun, Wenjie Guo, Yan Shen, Yongqian Shu, Xingxin Wu, Peifen Cai, Xuefeng Wu, Wen Liu and Xudong Wu and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Yanhong Gu

115 papers receiving 3.1k citations

Peers

Countries citing papers authored by Yanhong Gu

Since Specialization

Citations

This map shows the geographic impact of Yanhong Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanhong Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanhong Gu more than expected).

Fields of papers citing papers by Yanhong Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanhong Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanhong Gu. The network helps show where Yanhong Gu may publish in the future.

Co-authorship network of co-authors of Yanhong Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanhong Gu. A scholar is included among the top collaborators of Yanhong Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanhong Gu. Yanhong Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ferroptosis triggers anti-tumor immunity via promoting chaperone-mediated autophagic degradation of SHP2 2025 ·Redox Biology ·Jiazhen Zhu, Xiaofei Li, Wenbo Chen, (unknown), Qin Gong, (unknown), Kai Huang, Wen Liu, Yanhong Gu, Qiang Xu, Wenjie Guo	2
2	China special issue on gastrointestinal tumors‐Improved survival after multidisciplinary team decision for patients with advanced gastrointestinal cancer: A multicenter, noninterventional, controlled study 2023 ·International Journal of Cancer ·Qi Zhang, Ye Zhou, Lijie Song, Weijia Fang, Meng Qiu, Yanhong Gu, (unknown), Jingdong Zhang, Jing Liu, Jian Li, Ming Lu, (unknown), (unknown), Yan Li, H. J. Yang, Yingjiang Ye, Lin Shen	4
3	High Throughput Isolation and Data Independent Acquisition Mass Spectrometry (DIA-MS) of Urinary Extracellular Vesicles to Improve Prostate Cancer Diagnosis 2022 ·Molecules ·Hao Zhang, Guiyuan Zhang, (unknown), Ya‐Ting Chen, Yufeng Liu, (unknown), (unknown), (unknown), Yuxiang Liu, Shizhi Wang, Wenchao Li, Anke Wesselius, Maurice P. Zeegers, Ziyu Zhang, Yanhong Gu, W. Andy Tao, Evan Y. Yu	12
4	SHP2-Mediated Inhibition of DNA Repair Contributes to cGAS–STING Activation and Chemotherapeutic Sensitivity in Colon Cancer 2021 ·Cancer Research ·Bin Wei, Lingyan Xu, Wenjie Guo, Yuanyuan Wang, Jingjing Wu, Xiaofei Li, Xiaomin Cai, (unknown), Meijing Wang, Qiang Xu, Wen Liu, Yanhong Gu	65
5	Genomic Profiling Reveals the Molecular Landscape of Gastrointestinal Tract Cancers in Chinese Patients 2021 ·Frontiers in Genetics ·Chunrong Zhu, Liangjun Zhu, Yanhong Gu, Ping Liu, Xiaoling Tong, Guozhong Wu, Wenyu Zhu, Wenxiang Shen, Hua Bao, Xiangyuan Ma, Ruoying Yu, Xue Wu, Dongqin Zhu, Yongqian Shu, Jifeng Feng	9
6	175P A study of neoadjuvant sintilimab combined with triplet chemotherapy of lipo-paclitaxel, cisplatin, and S-1 for resectable esophageal squamous cell carcinoma (ESCC) 2020 ·Annals of Oncology ·Yanhong Gu, (unknown), (unknown), (unknown), Lijun Xue, Fuxi Zhen, Jing Xu, (unknown), Yao Li, (unknown), (unknown), Lingyan Xu, (unknown), Jiwei Luo	16
7	PUMA-mediated epithelial cell apoptosis promotes Helicobacter pylori infection-mediated gastritis 2020 ·Cell Death and Disease ·Yini Dang, Yifeng Zhang, Lingyan Xu, Xiaoying Zhou, Yanhong Gu, Jian Yu, Shidai Jin, (unknown), Yongqian Shu, Guoxin Zhang, Shiyun Cui, Jing Sun	17
8	Olaparib combined with immunotherapy for treating a patient with liver cancer carrying BRCA2 germline mutation 2020 ·Medicine ·Fengjiao Zhao, Yong Zhou, (unknown), Yihong Zhang, Siqin Liu, (unknown), Jun Hu, Yanhong Gu, Xiaofeng Chen	6
9	SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients 2018 ·BMC Cancer ·Zhu Mei, Yang Shao, (unknown), Xiaomin Cai, Biao Wang, Yan Ding, Xiangyuan Ma, Xue Wu, (unknown), Dongqin Zhu, Yongqian Shu, Zan Fu, Yanhong Gu	34
10	A fumigaclavine C isostere alleviates Th1-mediated experimental colitis via competing with IFN-γ for binding to IFN-γ receptor 1 2016 ·Biochemical Pharmacology ·Yang Tan, Xingxin Wu, Jing Sun, Wenjie Guo, Fang‐Yuan Gong, (unknown), Tao Tan, Yi Cao, Bingfeng Zheng, Yanhong Gu, Yang Sun, Qiang Xu	7
11	Erlotinib promotes endoplasmic reticulum stress-mediated injury in the intestinal epithelium 2014 ·Toxicology and Applied Pharmacology ·Lu Fan, Lingna Hu, (unknown), Xianying Fang, Zhe Gao, Wanshuai Li, Yang Sun, Yan Shen, Xuefeng Wu, Yongqian Shu, Yanhong Gu, Xudong Wu, Qiang Xu	20
12	A Novel Disease-Modifying Antirheumatic Drug, Iguratimod, Ameliorates Murine Arthritis by Blocking IL-17 Signaling, Distinct from Methotrexate and Leflunomide 2013 ·The Journal of Immunology ·Qiong Luo, Yang Sun, (unknown), Qian Cheng, Biaobing Jin, Feifei Tao, Yanhong Gu, Xingxin Wu, Yan Shen, Qiang Xu	80
13	Icotinib, a potent and specific EGFR tyrosine kinase inhibitor, inhibits growth of squamous cell carcinoma cell line A431 through negatively regulating AKT signaling 2013 ·Biomedicine & Pharmacotherapy ·Zhenzhen Gao, Wei Chen, Xiaohua Zhang, Peifen Cai, Xianying Fang, Qiang Xu, Yang Sun, Yanhong Gu	21
14	Axitinib, a selective inhibitor of vascular endothelial growth factor receptor, exerts an anticancer effect in melanoma through promoting antitumor immunity 2013 ·Anti-Cancer Drugs ·Xiaohua Zhang, Xianying Fang, Zhenzhen Gao, Wei Chen, Feifei Tao, Peifen Cai, (unknown), Yongqian Shu, Qiang Xu, Yang Sun, Yanhong Gu	27
15	Cerebroside D, a glycoceramide compound, improves experimental colitis in mice with multiple targets against activated T lymphocytes 2012 ·Toxicology and Applied Pharmacology ·Xuefeng Wu, Xingxin Wu, Wenjie Guo, Qiong Luo, Yanhong Gu, Yan Shen, Renxiang Tan, Yang Sun, Qiang Xu	12
16	Integrin α6high Cell Population Functions as an Initiator in Tumorigenesis and Relapse of Human Liposarcoma 2011 ·Molecular Cancer Therapeutics ·Lu Wang, (unknown), Yanhong Gu, Yongqian Shu, Yan Shen, Qiang Xu	19
17	Targeting Sarcoplasmic/Endoplasmic Reticulum Ca2+-ATPase 2 by Curcumin Induces ER Stress-Associated Apoptosis for Treating Human Liposarcoma 2011 ·Molecular Cancer Therapeutics ·Lu Wang, (unknown), Ran Song, Yan Shen, Yang Sun, Yanhong Gu, Yongqian Shu, Qiang Xu	71
18	Sorafenib induces apoptosis in HL60 cells by inhibiting Src kinase-mediated STAT3 phosphorylation 2010 ·Anti-Cancer Drugs ·Wei Zhao, (unknown), Bingqian Qu, Xingxin Wu, (unknown), Fanyu Meng, Yanhong Gu, Yongqian Shu, Yan Shen, Yang Sun, Qiang Xu	26
19	Human Renal Cancer Cells Express a Novel Membrane-Bound Interleukin-15 that Induces, in Response to the Soluble Interleukin-15 Receptor α Chain, Epithelial-to-Mesenchymal Transition 2009 ·Cancer Research ·(unknown), Julien Giron‐Michel, Yanhong Gu, Aurélie Perier, Massimo Giuliani, Anne Caignard, Aurore Devocelle, Silvano Ferrini, Marina Fabbi, Bernard Charpentier, Andreas Ludwig, Salem Chouaı̈b, Bruno Azzarone, Pierre Eid	40
20	The effect of dendritic cells activated by OK-432 and pulsed with antigens on cytokine induced killers 2006 ·Biomedicine & Pharmacotherapy ·Yongqian Shu, Yanhong Gu	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact